Recalcitrant Post-LASIK Mycobacterium chelonae Keratitis Eradicated after the Use of Fourth-Generation Fluoroquinolone

Ophthalmology

Volumn 113, Issue 6, 2006, Pages 950-954

  Hamam, Rola N ^a   Noureddin, Baha ^a   Salti, Haytham I ^a   Haddad, Randa ^a   Khoury, Johnny M ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DEXAMETHASONE; DEXAMETHASONE PLUS TOBRAMYCIN; GATIFLOXACIN; LEVOFLOXACIN; OFLOX; OFLOXACIN; PREDNISONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFACETAMIDE; TOBRAMYCIN; VANCOMYCIN;

ADULT; AMPUTATION; ARTICLE; BACTERIUM IDENTIFICATION; CASE REPORT; CULTURE MEDIUM; DEBRIDEMENT; EPITHELIUM; ERADICATION THERAPY; HUMAN; INOCULATION; KERATITIS; KERATOMILEUSIS; MALE; MEDICAL LITERATURE; MYCOBACTERIUM CHELONEI; PRIORITY JOURNAL;

ADULT; AMIKACIN; AMPUTATION; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; CORNEAL STROMA; DEBRIDEMENT; DRUG THERAPY, COMBINATION; EYE INFECTIONS, BACTERIAL; FLUOROQUINOLONES; HUMANS; KERATITIS; KERATOMILEUSIS, LASER IN SITU; MALE; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM INFECTIONS, ATYPICAL; OPHTHALMIC SOLUTIONS; POSTOPERATIVE COMPLICATIONS; SURGICAL FLAPS;

EID: 33646926123     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.02.028     Document Type: Article

References (39)

1. Solomon R., Donnenfeld E.D., Azar D.T., et al. Infectious keratitis after laser in situ keratomileusis. results of an ASCRS survey. J Cataract Refract Surg 29 (2003) 2001-2006
2. Reviglio V., Rodriguez M.L., Picotti G.S., et al. Mycobacterium chelonae keratitis following laser in situ keratomileusis. J Refract Surg 14 (1998) 357-360
3. Garg P., Bansal A.K., Sharma S., and Vemuganti G.K. Bilateral infectious keratitis after laser in situ keratomileusis a case report and review of the literature. Ophthalmology 108 (2001) 121-125
4. Chung M.S., Goldstein M.H., Driebe Jr. W.T., and Schwartz B.H. Mycobacterium chelonae keratitis after laser in situ keratomileusis successfully treated with medical therapy and flap removal. Am J Ophthalmol 129 (2000) 382-384
5. Kouyoumdjian G.A., Forstot S.L., Durairaj V.D., and Damiano R.E. Infectious keratitis after laser refractive surgery. Ophthalmology 108 (2001) 1266-1268
6. Solomon A., Karp C.L., Miller D., et al. Mycobacterium interface keratitis after laser in situ keratomileusis. Ophthalmology 108 (2001) 2201-2208
7. Chandra N.S., Torres M.F., Winthrop K.L., et al. Cluster of Mycobacterium chelonae keratitis cases following laser in-situ keratomileusis. Am J Ophthalmol 132 (2001) 819-830
8. Holmes G.P., Bond G.B., Fader R.C., and Fulcher S.F. A cluster of cases of Mycobacterium szulgai keratitis that occurred after laser-assisted in situ keratomileusis. Clin Infect Dis 34 (2002) 1039-1046
9. Fulcher S.F.A., Fader R.C., Rosa Jr. R.H., and Holmes G.P. Delayed-onset mycobacterial keratitis after LASIK. Cornea 21 (2002) 546-554
10. Giaconi J., Pham R., and Ta C.N. Bilateral Mycobacterium abscessus keratitis after laser in situ keratomileusis. J Cataract Refract Surg 28 (2002) 887-890
11. Alvarenga L., Freitas D., Hofling-Lima A.L., et al. Infectious post LASIK crystalline keratopathy caused by nontuberculous mycobacteria. Cornea 21 (2002) 426-429
12. Pache M., Schipper I., Flammer J., and Meyer P. Unilateral fungal and mycobacterial keratitis after simultaneous laser in situ keratomileusis. Cornea 22 (2003) 72-75
13. Verma S., Watson S.L., Dart J.K., and Eykyn S.J. Bilateral Mycobacterium chelonae keratitis following LASIK [letter]. J Refract Surg 19 (2003) 379-380
14. Winthrop K.L., Steinberg E.B., Holmes G., et al. Epidemic and sporadic cases of nontuberculous mycobacterial keratitis associated with laser in situ keratomileusis. Am J Ophthalmol 135 (2003) 223-224
15. Karp C.L., Tuli S.S., Yoo S.H., et al. Infectious keratitis after LASIK. Ophthalmology 110 (2003) 503-510
16. Freitas D., Alvarenga L., Sampaio J., et al. An outbreak of Mycobacterium chelonae infection after LASIK. Ophthalmology 110 (2003) 276-285
17. Sun Y.C., Wang I.J., Chen W.L., and Hu F.R. Therapeutic keratectomy for Mycobacterium abscessus keratitis after LASIK. J Formos Med Assoc 102 (2003) 805-807
18. Seo K.Y., Lee J.B., Lee K., et al. Non-tuberculous mycobacterial keratitis at the interface after laser in situ keratomileusis. J Refract Surg 18 (2002) 81-85
19. Gelender H., Carter H.L., Bowman B., et al. Mycobacterium keratitis after laser in situ keratomileusis. J Refract Surg 16 (2000) 191-195
20. Becero F., Maestre J.R., Buezas V., et al. Keratitis due to Mycobacterium chelonae after refractive surgery with LASIK [in Spanish] [letter]. Enferm Infecc Microbiol Clin 20 (2002) 44-45
21. Fogla R., Rao S.K., and Padmanabhan P. Interface keratitis due to Mycobacterium fortuitum following laser in situ keratomaleusis. Indian J Ophthalmol 51 (2003) 263-265
22. Kohnen T., Schopfer D., Buhren J., and Hunfeld K.P. Flap amputation in Mycobacterium chelonae keratitis after laser in situ keratomileusis (LASIK) [in German]. Klin Monatsbl Augenheilkd 220 (2003) 634-637
23. Gillespie S.H., Morrissey I., and Everett D. A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum model. J Med Microbiol 50 (2001) 565-570
24. Tomioka H., Saito H., and Sato K. Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin. Antimicrob Agents Chemother 37 (1993) 1259-1263
25. Brown-Elliot B.A., Wallace Jr. R.J., Crist C.J., et al. Comparison of in vitro activities of gatifloxacin and ciprofloxacin against four taxa of rapidly growing mycobacteria. Antimicrob Agents Chemother 46 (2002) 3283-3285
26. Rodrigeuz Diaz J.C., Lopez M., Ruiz M., and Royo G. In vitro activity of new fluoroquinolones and linezolid against non-tuberculous mycobacteria. Int J Antimicrob Agents 21 (2003) 585-588
27. Gillespie S.H., and Billington O. Activity of moxifloxacin against mycobacteria. J Antimicrob Chemother 44 (1999) 393-395
28. Hyon J.Y., Joo M.J., Hose S., et al. Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis. Arch Ophthalmol 122 (2004) 1166-1169
29. Duffey R.J., and Leaming D. US trends in refractive surgery. 2003 ISRS/AAO survey. J Refract Surg 21 (2005) 87-91
30. John T., and Vellota E. Nontuberculous (atypical) mycobacterial keratitis after LASIK. current status and clinical implications. Cornea 24 (2005) 245-255
31. Ford J.G., Huang A.J.W., Pflugfelder S.C., et al. Nontuberculous mycobacterial keratitis in south Florida. Ophthalmology 105 (1998) 1652-1658
32. Eiferman R.A., and Stagner J.I. Intraocular penetration of amikacin. Iris binding and bioavailability. Arch Ophthalmol 100 (1982) 1817-1819
33. Gross R.H., Holland G.N., Elias S.J., and Tuz R. Corneal pharmacokinetics of topical clarithromycin. Invest Ophthalmol Vis Sci 36 (1995) 965-968
34. Hu F.R., and Luh K.T. Topical ciprofloxacin for treating notuberculous mycobacterial keratitis. Ophthalmology 105 (1998) 269-272
35. Hwang D.G., and Biswell R. Ciprofloxacin therapy of Mycobacterium chelonae keratitis. Am J Ophthalmol 115 (1993) 114-115
36. Wallace Jr. R.J., Bedsole G., Sumter G., et al. Activities of ciprofloxacin and ofolxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Antimicrob Agents Chemother 34 (1990) 65-70
37. Tipperman R. Pharmacologic considerations for cataract surgery. Curr Opin Ophthalmol 15 (2004) 51-55
38. Saito H. Comparative antimycobacterial activity of BAY 12-8039 and gatifloxacin. Drugs 58 suppl (1999) 400-401
39. Callegan M.C., Ramirez R., Kane S.T., et al. Antibacterial activity of the fourth-generation flouroquinolones gatifloxacin and moxifloxacin against ocular pathogens. Adv Ther 20 (2003) 246-252